Lundbeck poaches CSO from US biotech firm
Lundbeck has been on the prowl at US biotech company Immunitas Therapeutics, where it has found its new Head of Research with responsibility for drug discovery and early clinical development.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Lundbeck has now found the person who will be in charge of accelerating the Danish pharmaceutical company's drug discovery and early clinical development research.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
New Lundbeck exec to get firm's next research leg started
For subscribers
